On November 16th at 5 a.m. EST (November 16th at 4 p.m. Beijing time), RELX (Wuxin Technology), also known as Yooz, released their Q3 2022 financial report on the NASDAQ. The report highlighted several key data points.
Net income decreased by 37.7% from 16.767 billion yuan to 10.444 billion yuan. Gross profit margin increased by 10.9% to 50% from the previous year's 39.1%. Under U.S. GAAP adjustments, net income decreased by 48.4% from 9.764 billion yuan to 5.052 billion yuan. Unadjusted net income decreased by 27.4% from 4.527 billion yuan to 3.286 billion yuan from the same period last year.
Furthermore, YUEKE's R&D investment in Q3 2022 was 46 million yuan, a slight increase from the 44.6 million yuan invested during the same period in 2021.
Tomorrow, 2FIRSTS will present a more comprehensive overview of "Yueke's Q3 2022 financial report." Click here to view the content of Yueke's Q2 2022 financial report.
Statement:
1. This article is intended solely for research and discussion among industry insiders and does not make any investment or brand recommendations. It should not be used as a basis for investment decisions. 2. The data and analytical conclusions cited in this article have not been confirmed in writing by the companies mentioned. All data should be based on official company releases.
This article is an original piece created by Shenzhen 2FIRSTS Technology Co., Ltd. Ownership and licensing rights belong to the company, and unauthorized commercial reproduction, copying, or any other use that violates the company's copyright is strictly prohibited. Those who violate these terms may face legal consequences.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
